dabrafenib plus trametinib preferable to vemurafenib alone in melanoma
Published 9 years ago • 303 plays • Length 5:05Download video MP4
Download video MP3
Similar videos
-
7:05
improved response rate and survival with dabrafenib plus trametinib vs vemurafenib alone in melanoma
-
5:13
dabrafenib plus trametinib improves melanoma patients’ survival
-
1:49
combi-ad: dabrafenib plus trametinib in advanced melanoma
-
0:48
dr. michael rotkowitz on the dabrafenib plus trametinib combination for melanoma
-
1:08
dr. weber on dabrafenib/trametinib versus vemurafenib/cobimetinib in melanoma
-
6:16
dabrafenib plus trametinib for stage iii mutant melanoma
-
3:05
dabrafenib and trametinib: a promising combination for the treatment of melanoma
-
2:16
dr. rodabe n. amaria on dabrafenib plus trametinib in melanoma
-
4:45
combi-ad trial: adjuvant dabrafenib plus trametinib in patients with resected stage iii braf v60...
-
2:33
dr. sullivan discusses role of dabrafenib plus trametinib in melanoma
-
0:56
5-year follow-up: dabrafenib plus trametinib reduces relapse risk in melanoma
-
0:53
dabrafenib plus trametinib demonstrates benefit in braf-mutant melanoma
-
3:06
combi-d: phase 3 trial of dabrafenib plus trametinib in braf v600e/k-mutated melanoma
-
0:59
the success of the dabrafenib and trametinib combination in braf-mutated melanoma
-
1:04
dr. wilson on long-term data with dabrafenib plus trametinib in melanoma
-
1:08
fda approval of adjuvant dabrafenib/trametinib in braf melanoma
-
1:24
adverse events with dabrafenib/trametinib combination in melanoma
-
2:46
long-term outcomes with dabrafenib plus trametinib in braf v600-mutant melanoma
-
0:30
dr. postow on fda approval of adjuvant dabrafenib plus trametinib in braf-mutant melanoma